Determination of Ki67 Growth Fraction and Oestrogen Receptors In Screen‐Detected Breast Cancer Using Cytological Preparations
- 1 October 1993
- journal article
- Published by Wiley in Cytopathology
- Vol. 4 (5) , 257-266
- https://doi.org/10.1111/j.1365-2303.1993.tb00100.x
Abstract
Oestrogen receptor (ER) status of 77 cases of screen‐detected breast cancer has been determined using cytological preparations. In 48% ER status was positive, which was the same proportion as that formed in a control group of age‐matched patients with symptomatic breast carcinoma. Since the screen‐detected group contained more low grade tumours, the percentage of ER‐positive cases would be expected to be higher. the reasons for the discrepancy are discussed. Ki67 score has been determined for 41 cases of screen‐detected cancer. Ki67 score showed a positive correlation with histological tumour grade and a negative correlation with ER status. However, there was no correlation with tumour size or lymph node status. the Ki67 scores in the screen‐detected cancers were essentially similar to those found in an age‐matched symptomatic group, but the very low scores were only found in the screened group.Keywords
This publication has 14 references indexed in Scilit:
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytologyCytopathology, 1990
- Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological studyHistopathology, 1989
- DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potentialInternational Journal of Cancer, 1988
- Immunohistochemistry of Estrogen Receptor Protein in Paraffin Sections: Effects of Enzymatic Pretreatment and Cobalt Chloride IntensificationAmerican Journal of Clinical Pathology, 1988
- Immunocytochemical staining of proliferating cells in fine needle aspiration smears of primary and metastatic breast tumoursBritish Journal of Cancer, 1988
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.Journal of Clinical Pathology, 1986
- THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER*Anz Journal of Surgery, 1984
- ŒSTROGEN RECEPTORS AND PROGNOSIS IN EARLY BREAST CANCERThe Lancet, 1979